CINECA IRIS Institutional Research Information System
IRIS è il sistema di gestione integrata dei dati della ricerca (persone, progetti, pubblicazioni, attività) adottato dall'Università degli Studi di Torino.
AperTO è l'archivio istituzionale Open Access destinato a raccogliere, rendere visibile e conservare la produzione scientifica dell'Università degli Studi di Torino.
ItalianoVITALE, Candida
Pubblicazioni
Risultati 1 - 20 di 123 (tempo di esecuzione: 0.001 secondi).
| Titolo | Data di pubblicazione | Autore(i) | |
|---|---|---|---|
| 1 | Abstract 2072: Selinexor in combination with chemotherapy or idelalisib elicits a synergistic cytotoxic effect in primary CLL cells | 2019 | Todaro Maria, Griggio Valentina, Salvetti Chiara, Riganti Chiara, Landesman Yosef, Boccadoro Mario, Vitale Candida, Coscia Marta |
| 2 | Accelerated activity of the mevalonate pathway supports the immune escape and multidrug-resistance phenotype of IGHV unmutated chronic lymphocytic leukemia cells | 2011 | M Coscia; M Rigoni; C Riganti; I Campia; C Vitale; V Griggio; S Peola; B Castella; F Pantaleoni; P Sciancalepore; D Drandi; P Omedè; M Ladetto; A Bosia; M Boccadoro; M Massaia |
| 3 | Acute promyelocytic leukemia presented as a relapse of acute myeloid leukemia | 2016 | Vitale, Candida; Jabbour, Elias; Lu, Xinyan; Yabe, Mariko; Shamanna, Rashmi Kanagal; Daver, Naval; Pemmaraju, Naveen; Bueso-Ramos, Carlos E.; Takahashi, Koichi* |
| 4 | Adoptive immunotherapy with CAR modified T cells in cancer: current landscape and future perspectives | 2019 | Marta Coscia, Candida Vitale, Marco Cerrano, Enrico Maffini, Luisa Giaccone, Mario Boccadoro, Benedetto Bruno |
| 5 | The Advent of CAR T-Cell Therapy for Lymphoproliferative Neoplasms: Integrating Research Into Clinical Practice | 2020 | Cerrano M.; Ruella M.; Perales M.-A.; Vitale C.; Faraci D.G.; Giaccone L.; Coscia M.; Maloy M.; Sanchez-Escamilla M.; Elsabah H.; Fadul A.; Maffini E.; Pittari G.; Bruno B. |
| 6 | Anergic bone marrow Vγ9Vδ2 T cells as early and long-lasting markers of PD-1-targetable microenvironment-induced immune suppression in human myeloma | 2015 | Castella, B; Foglietta, M; Sciancalepore, P; Rigoni, M; Coscia, M; Griggio, V; Vitale, C; Ferracini, R; Saraci, E; Omedé, P; Riganti, C; Palumbo, A; Boccadoro, M; Massaia, M. |
| 7 | Autoimmune complications in chronic lymphocytic leukemia in the era of targeted drugs | 2020 | Vitale C.; Montalbano M.C.; Salvetti C.; Boccellato E.; Griggio V.; Boccadoro M.; Coscia M. |
| 8 | Autoimmune cytopenias in patients with chronic lymphocytic leukemia treated with ibrutinib | 2016 | Vitale, Candida; Ahn, Inhye E.; Sivina, Mariela; Ferrajoli, Alessandra; Wierda, William G.; Estrov, Zeev; Konoplev, Sergej N.; Jain, Nitin; O’Brien, Susan; Farooqui, Mohammed; Keating, Michael J.; Wiestner, Adrian; Burger, Jan A.* |
| 9 | Bendamustine and alemtuzumab (BEN CAM) combination in relapsed and refractory chronic lymphocytic leukaemia (CLL): interim report of the italian trial | 2011 | A Tedeschi; M Coscia; D Rossi; F Ricci; G D'Arena; E Orlandi; V Belsito Petrizzi; L Scarfò; C Vitale; E Vismara; G Gaidano; E Morra; M Massaia; M Montillo |
| 10 | BENDAMUSTINE AND ALEMTUZUMAB (BEN CAM) COMBINATION IN RELAPSED AND REFRACTORY CHRONIC LYMPHOCYTIC LEUKAEMIA (CLL): PHASE I SAFETY PROFILE RESULTS OF THE ITALIAN TRIAL | 2010 | A Tedeschi ;M Coscia ;D Rossi ;E Vismara ;F Ricci ;C Vitale ;E Morra ;G Gaidano ;M Massaia ;M Montillo |
| 11 | BENDAMUSTINE AND ALEMTUZUMAB (BEN CAM) COMBINATION IN RELAPSED AND REFRACTORY CHRONIC LYMPHOCYTIC LEUKAEMIA (CLL): PRELIMINARY REPORT OF THE ITALIAN TRIAL | 2011 | Tedeschi, A; Coscia, M; Rossi, D; Ricci, F; D'Arena, G; Orlandi, E; Petrizzi, Vb; Scarfo, L; Vitale, C; Vismara, E; Gaidano, G; Morra, E; Massaia, M; Montillo, M |
| 12 | Bendamustine and Alemtuzumab combination in relapsed and refractory chronic lymphocytic leukemia: interim report of the italian trial | 2011 | A Tedeschi; M Coscia; D Rossi; F Ricci; G D'Arena; E Orlandi; V Belsito Petrizzi; L Scarfò; C Vitale; E Vismara; G Gaidano; E Morra; M Massaia; M Montillo |
| 13 | Bleeding diathesis associated with acquired von Willebrand Syndrome in three patients with chronic lymphocytic leukemia | 2014 | Candida Vitale; Mona Lisa Alattar; Maria Ciccone; Mahmoud R Gaballa; Xavier C Badoux; George Manoukian; Michael J Keating; Michael H Kroll; Alessandra Ferrajoli |
| 14 | Bleeding diathesis associated with acquired von Willebrand Syndrome in three patients with chronic lymphocytic leukemia | 2015 | Alattar, Mona Lisa; Ciccone, Maria; Gaballa, Mahmoud R.; Vitale, Candida; Badoux, Xavier C.; Manoukian, George; Keating, Michael J.; Kroll, Michael H.; Ferrajoli, Alessandra* |
| 15 | CAR T-Cell Therapy for B-Cell non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia: Clinical Trials and Real-World Experiences | 2020 | Vitale C.; Strati P. |
| 16 | CD200 and prognosis in chronic lymphocytic leukemia: Conflicting results | 2019 | D'Arena G.; Valvano L.; Vitale C.; Coscia M.; Statuto T.; Bellesi S.; Lamorte D.; Musto P.; Laurenti L.; D'Auria F. |
| 17 | CD200 included in a 4-marker modified Matutes score provides optimal sensitivity and specificity for the diagnosis of chronic lymphocytic leukaemia | 2018 | D'Arena, Giovanni*; Vitale, Candida; Rossi, Giovanni; Coscia, Marta; Omedè, Paola; D'Auria, Fiorella; Statuto, Teodora; Valvano, Luciana; Ciolli, Stefania; Gilestro, Milena; Molica, Stefano; Bellesi, Silvia; Topini, Giuseppe; Panichi, Valentina; Autore, Francesco; Innocenti, Idanna; Musto, Pellegrino; Deaglio, Silvia; Laurenti, Luca; Del Vecchio, Luigi |
| 18 | CD200 INCLUDED IN A 4-MARKER MODIFIED MATUTES SCORE PROVIDES OPTIMAL SENSITIVITYAND SPECIFICITY FOR THE DIAGNOSIS OF CHRONIC LYMPHOCYTIC LEUKEMIA | 2018 | D'Arena, G; Vitale, C; Rossi, G; Coscia, M; Omede, P; D'Auria, F; Statuto, T; Valvano, L; Ciolli, S; Gilestro, M; Molica, S; Bellesi, S; Topini, G; Panichi, V; Autore, F; Innocenti, I; Musto, P; Deaglio, S; Laurenti, L; Del Vecchio, L |
| 19 | Centralized Biobanking Supports Hematology Clinical Trials: the new challenge of the University of Torino | 2019 | Gian Maria Zaccaria, Daniela Drandi, Simona Caltagirone, Martina Ferrante, Marco Ghislieri, Daniela Barbero, Marina Ruggeri, Barbara Mantoan, Elisa Genuardi, Daniela Oddolo, Giuseppe Lia, Valentina Griggio, Pierpaola Fenoglio, Mattia D’Agostino, Candida Vitale, Marta Coscia, Benedetto Bruno, Stefania Oliva, Paola Omedè, Alessandra Larocca, Simone Ferrero, Mario Boccadoro |
| 20 | Changes in lymphocyte subsets, angiogenic factors and plasma cytokines in patients with chronic lymphocytic leukemia during treatment with Ofatumumab and Lenalidomide | 2015 | Vitale C, ten Hacken E, Gao H, Keating MJ, O’Brien S, Wierda WG, Falchi L, Reuben J, Burger JA, Calin G, Ferrajoli A |
Dettaglio
VITALE, Candida
BIOTECNOLOGIE MOLECOLARI E SCIENZE PER LA SALUTE
Copyright © 2020